title: Interferon and other therapies for hepatitis B and hepatitis C infections.
abstract: Interferon is currently the only approved medication in the United States for treatment of chronic hepatitis B and C infections. The mechanism of action of interferon and guidelines for its administration are reviewed. Important clinical studies involving its use in hepatitis B and C infections are discussed, and investigational therapies for chronic viral hepatitis are highlighted.
authors.affiliation: Center for Liver Diseases, Albert Einstein Medical Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: K D
authors.initials: KD
authors.lastname: Rothstein
authors.forename: S J
authors.initials: SJ
authors.lastname: Munoz
mesh_terms: D002908:Chronic Disease; D006509:Hepatitis B / Q000628:therapy*; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016031:Liver Transplantation
chemical_list: D007372:Interferons